XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2022
Cash flows from operating activities:          
Net loss $ (5,995) $ 5,980 $ (11,348) $ (1,072)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Inventory write-off 19 60 56 194  
Depreciation and amortization     465 405  
Amortization of operating lease right-of-use assets     286    
Perpetual licensing revenue from a related party     0 (8,000)  
Stock-based compensation     1,219 1,008  
Interest cost     4 108  
Gain on sale of equipment     (110) 0  
Loss in joint venture     1,266 1,127  
Changes in fair value of promissory note 0 (1,629) 0 (605)  
Changes in operating assets and liabilities:          
Accounts receivable     941 33  
Inventory     (2,692) (2,745)  
Prepaid expenses and other current assets     (97) 124  
Other assets     (521) 15  
Accounts payable and accrued expenses     904 657  
Deferred revenue     (83) 102  
Accrued payroll and benefits     160 37  
Operating lease liabilities     (263)    
Net cash used in operating activities     (9,813) (8,612)  
Cash flows from investing activities:          
Purchases of property and equipment     (4,026) (409)  
Proceeds from sale of equipment     110 0  
Investment in joint venture     (1,537) (3,081)  
Net cash used in investing activities     (5,453) (3,490)  
Cash flows from financing activities:          
Proceeds from stock option exercise     56 134  
Proceeds from issuance of common stock     16,000 5,000  
Cost associated with issuance of common stock     (280) 0  
Payment for taxes related to net share settlement of restricted stock units     (6) 0  
Net cash provided by financing activities     15,770 5,134  
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash     (443) (44)  
Net increase (decrease) in cash, cash equivalents and restricted cash     61 (7,012)  
Cash, cash equivalents and restricted cash at beginning of period     33,435 9,500 $ 9,500
Cash and cash equivalents 33,496 1,988 33,496 1,988 33,435
Restricted cash at end of period 500 500 500 500  
Cash, cash equivalents and restricted cash at end of period $ 33,996 $ 2,488 33,996 2,488 $ 33,435
Supplemental disclosures of cash flow information:          
Interest expense paid     362 316  
Supplemental non-cash investing activity:          
Equipment purchases     0 250  
Supplemental non-cash financing activity:          
Issuance of shares in connection with a service contract     0 500  
Operating lease right-of-use asset obtained in exchange for operating lease liabilities     3,598 0  
Development loan reduction related to perpetual licensing revenue     $ 0 $ 8,000